Cancer Pain Market Global Industry Analysis by Top Key Players, Types, Key Regions Demand and Future Growth till 202

The global cancer pain market size accounted for $5.53 Billion in 2018 and is projected to reach $7.54 billion by 2025, registering a CAGR of 4.5% during the forecast period.

"Cancer Pain Market by Drug Type (Opioids, Non-Opioids, and Nerve Blockers) and Disease Indication (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025."

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5123

The global cancer pain market is divided on the basis of type, disease indication, and region. Based on type, the market is segmented into opioids, non-opioids, and nerve blockers. The opioids segment held the largest share in 2018, contributing more than half of the market and is expected to continue its dominance throughout the study period. In addition, the segment is estimated to register the fastest CAGR of 5.0% during the forecast period.

Opioids segment to continue its dominant position throughout the forecast period

Based on drug type, the opioids segment contributed the highest market share in 2018, accounting for nearly three-fifths of the total share, and is expected to continue its dominant position throughout the forecast period. Moreover, this segment is expected to grow at the highest CAGR of 5.0% from 2018 to 2025. This is attributed to rise in adoption of opioids for management of cancer pain and their nature of being the FDA-approved first line drugs for treating moderate or severe chronic cancer pain. The report also analyzes non-opioids and nerve blockers segments. The report also analyzes colorectal cancer, breast cancer, prostate cancer, blood cancer, and others.

North America to maintain its highest share by 2025

Based on region, North America accounted for the major market share in 2018, accounting for more than two-fifths of the total market share. This region is expected to maintain its highest share during the forecast period. This is due to rapid increase in prevalence of different types of cancers, advancements in technologies, ease in availability of pain therapeutics, and availability of premiere chemotherapy treatments. On the other hand, Asia-Pacific would register the fastest growth rate with a CAGR of 5.4% from 2018 to 2025, owing to rise in prevalence of cancer in China, Japan, and India, increase in early screening of cancer, and surge in availability of pain therapeutics.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5123

The global cancer pain market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across the Asia-pacific region is estimated to manifest the fastest CAGR of 5.4% during the forecast period. However, the market across North America held the largest share in 2018, contributing more than two-fifths of the market.

The global cancer pain market report provides an in-depth analysis of the major market players such as BioDelivery Sciences International, Inc., Aoxing Pharmaceutical Company, Inc., Grnenthal Pharma GmbH & Co. KG, Daiichi Sankyo Co., Ltd., Insys Therapeutics, Inc., Hisamitsu Pharmaceutical Co., Inc., Orexo AB, Mundipharma International Limited, Teva Pharmaceutical Industries Limited, and Pfizer Inc.

Access Full Report @ https://www.alliedmarketresearch.com/cancer-pain-market

Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.